Ohio State University Comprehensive Cancer Center: Multiple Myeloma trials
The registry lists 14 Multiple Myeloma studies with Ohio State University Comprehensive Cancer Center as lead sponsor. 2 are open to participants now and 2 have results posted.
Phase 1 3Phase 2 3No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin LymphomaRecruitingNCT07609030Not applicable
- Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample ResourceRecruitingNCT01408225
- Daratumumab in Treating Patients With Multiple MyelomaCompletedNCT02944565Phase 2Results posted
- Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk LymphomaCompletedNCT00569309Not applicableResults posted
- Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)SuspendedNCT07102212Not applicable
- Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS StudyCompletedNCT05972577Not applicable
- Study of Personalized Melphalan Dosing in the Setting of Autologous TransplantWithdrawnNCT03328936Phase 2
- HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple MyelomaCompletedNCT02569320Phase 1
- Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT02077959Phase 1
- Comprehensive Frailty AssessmentCompletedNCT02033928
- Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer SurvivorsCompletedNCT01929720Not applicable
- Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma PatientsCompletedNCT01653106Not applicable
- Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00729118Phase 1
- Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple MyelomaCompletedNCT00201695Phase 2